Kongshanci Technology secures Pre-A funding to accelerate clinical translation of its brain-computer interaction and neuromodulation platform

Kongshanci Technology, a company specializing in non-invasive brain-computer interface (BCI) and neuromodulation, recently announced the completion of its Pre-A funding round. This round was exclusively led by Yunqi Partners. The proceeds will be primarily utilized for core technology research and development, clinical translation, and global expansion.

As a next-generation full-stack technology platform addressing neurological needs, Kongshanci Technology applies its multi-dimensional brain signal analysis capabilities to modulation methods such as ultrasound, magnetic stimulation, electrical stimulation, and optical stimulation. By deeply integrating AI throughout the entire process of diagnosis, treatment, and management, Kongshanci Technology creates a technological feedback loop enabling continuous iteration between clinical data and intervention protocols, thereby providing a systemic solution for the treatment of brain functional disorders.

Regarding clinical progress, Kongshanci Technology has established an in-depth research collaboration with the National Center for Mental Health. Breakthroughs have been achieved in early-stage clinical investigations, demonstrating significant symptom improvement within a short intervention period. This showcases an uncommon level of efficacy and leading potential in the non-invasive BCI field, with related outcomes also attracting attention and recognition from prominent overseas academic institutions.

Following a technology implementation pathway from "research to clinic to home," Kongshanci Technology is strategically developing a product matrix covering diverse scenarios. Kongshanci Technology aims to provide patients and users with brain science solutions that offer both significant clinical value and technological leadership.

The completion of this funding round signifies strong capital market recognition of Kongshanci Technology's technological expertise and clinical value. With the support of Yunqi Partners, the team will accelerate technological iteration and clinical translation, continuously strengthening its core competitive advantages. Looking ahead, Kongshanci Technology will persist in its deep focus on brain-computer interaction and neuromodulation, striving to become a globally leading intelligent infrastructure platform for brain science and promoting the advancement of cutting-edge technologies from the laboratory to the clinic and ultimately into the home.